Novavax preps to meet global demand, plans capacity for 2B Covid vaccine doses

Novavax says it’s building up its manufacturing capacity now to be ready to ship Covid-19 vaccine globally as emergency authorizations are granted in coming months. The company expects to seek FDA authorization in the second quarter.